D. Poulain, Candida albicans, plasticity and pathogenesis, Crit. Rev. Microbiol, vol.41, pp.208-217, 2015.

B. J. Kullberg and M. C. Arendrup, Invasive candidiasis, N. Engl. J. Med, vol.373, pp.1445-1456, 2015.

N. A. Gow, F. L. Van-de-veerdonk, A. J. Brown, and M. G. Netea, Candida albicans morphogenesis and host defence: Discriminating invasion from colonization, Nat. Rev. Microbiol, vol.10, pp.112-122, 2012.

B. Sendid, N. Dotan, S. Nseir, C. Savaux, P. Vandewalle et al., Antibodies against glucan, chitin, and saccharomyces cerevisiae mannan as new biomarkers of candida albicans infection that complement tests based on c. Albicans mannan, Clin. Vaccine Immunol, vol.15, pp.1868-1877, 2008.

D. N. Frank, A. L. St-amand, R. A. Feldman, E. C. Boedeker, N. Harpaz et al., Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases, Proc. Natl. Acad. Sci, vol.104, pp.13780-13785, 2007.

A. Standaert-vitse, B. Sendid, M. Joossens, N. Francois, P. Vandewalle-el-khoury et al., Candida albicans colonization and asca in familial crohn's disease, Am. J. Gastroenterol, vol.104, pp.1745-1753, 2009.

S. Jawhara and D. Poulain, Saccharomyces boulardii decreases inflammation and intestinal colonization by candida albicans in a mouse model of chemically-induced colitis, Med. Mycol, vol.45, pp.691-700, 2007.

S. Jawhara, X. Thuru, A. Standaert-vitse, T. Jouault, S. Mordon et al., Colonization of mice by candida albicans is promoted by chemically induced colitis and augments inflammatory responses through galectin-3, J. Infect. Dis, vol.197, pp.972-980, 2008.

S. Jawhara, E. Mogensen, F. Maggiotto, C. Fradin, A. Sarazin et al., Murine model of dextran sulfate sodium-induced colitis reveals candida glabrata virulence and contribution of beta-mannosyltransferases, J. Biol. Chem, vol.287, pp.11313-11324, 2012.

E. E. Perez, J. S. Orange, F. Bonilla, J. Chinen, I. K. Chinn et al., Update on the use of immunoglobulin in human disease: A review of evidence, J. Allergy Clin. Immunol, vol.139, pp.1-46, 2017.

L. Gilardin, J. Bayry, and S. V. Kaveri, Intravenous immunoglobulin as clinical immune-modulating therapy, CMAJ, vol.187, pp.257-264, 2015.

J. D. Lunemann, F. Nimmerjahn, and M. C. Dalakas, Intravenous immunoglobulin in neurology-mode of action and clinical efficacy, Nat. Rev. Neurol, vol.11, pp.80-89, 2015.

C. Galeotti, S. V. Kaveri, and J. Bayry, Ivig-mediated effector functions in autoimmune and inflammatory diseases, Int. Immunol, vol.29, pp.491-498, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01723555

, Int. J. Mol. Sci, vol.20, p.1473, 2019.

C. Bruckner, C. Lehmann, D. Dudziak, and F. Nimmerjahn, Sweet signs: Igg glycosylation leads the way in ivig-mediated resolution of inflammation, Int. Immunol, vol.29, pp.499-509, 2017.

M. Rogosnitzky, R. Danks, and D. Holt, Intravenous immunoglobulin for the treatment of crohn's disease, Autoimmun. Rev, vol.12, pp.275-280, 2012.

M. Wang, C. Liang, H. Hu, L. Zhou, B. Xu et al., Intraperitoneal injection (ip), intravenous injection (iv) or anal injection (ai)? Best way for mesenchymal stem cells transplantation for colitis

M. T. Castelo-branco, I. D. Soares, D. V. Lopes, F. Buongusto, C. A. Martinusso et al., Intraperitoneal but not intravenous cryopreserved mesenchymal stromal cells home to the inflamed colon and ameliorate experimental colitis, PLoS ONE, vol.7, 2012.

J. Bayry, S. Lacroix-desmazes, M. D. Kazatchkine, and S. V. Kaveri, Intravenous immunoglobulin for infectious diseases: Back to the pre-antibiotic and passive prophylaxis era?, Trends Pharm. Sci, vol.25, pp.306-310, 2004.

B. A. Diep, V. T. Le, C. Badiou, H. N. Le, M. G. Pinheiro et al., Ivig-mediated protection against necrotizing pneumonia caused by mrsa, Sci. Transl. Med, vol.8, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01911475

B. Shopsin, S. V. Kaveri, and J. Bayry, Tackling difficult staphylococcus aureus infections: Antibodies show the way, Cell Host Microbe, vol.20, pp.555-557, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01398083

D. Ben-nathan, S. Lustig, G. Tam, S. Robinzon, S. Segal et al., Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating west nile virus infection in mice, J. Infect. Dis, vol.188, pp.5-12, 2003.

V. Gauduchon, G. Cozon, F. Vandenesch, A. L. Genestier, N. Eyssade et al., Neutralization of staphylococcus aureus panton valentine leukocidin by intravenous immunoglobulin in vitro, J. Infect. Dis, vol.189, pp.346-353, 2004.

I. Krause, R. Wu, Y. Sherer, M. Patanik, J. B. Peter et al., In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations-A potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases, Transfus Med, vol.12, pp.133-139, 2002.

R. Srivastava, C. Ramakrishna, and E. Cantin, Anti-inflammatory activity of intravenous immunoglobulins protects against west nile virus encephalitis, J. Gen. Virol, vol.96, pp.1347-1357, 2015.

C. Ramakrishna, A. N. Newo, Y. W. Shen, and E. Cantin, Passively administered pooled human immunoglobulins exert il-10 dependent anti-inflammatory effects that protect against fatal hsv encephalitis, PLoS Pathog, 2011.

S. R. Elluru, S. V. Kaveri, and J. Bayry, The protective role of immunoglobulins in fungal infections and inflammation, Semin Immunopathol, vol.37, pp.187-197, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01103153

A. Casadevall and L. A. Pirofski, Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases, Cell Host Microbe, vol.11, pp.447-456, 2012.

R. J. Stratta, M. S. Shaefer, K. A. Cushing, R. S. Markin, E. C. Reed et al., A randomized prospective trial of acyclovir and immune globulin prophylaxis in liver transplant recipients receiving okt3 therapy, Arch. Surg, vol.127, pp.55-63, 1992.

D. Mimouni, M. Gdalevich, F. B. Mimouni, I. Grotto, A. Eldad et al., Does immune serum globulin confer protection against skin diseases?, Int. J. Derm, vol.39, pp.628-631, 2000.

J. Tollemar, N. Gross, N. Dolgiras, C. Jarstrand, O. Ringden et al., Fungal prophylaxis by reduction of fungal colonization by oral administration of bovine anti-candida antibodies in bone marrow transplant recipients, Bone Marrow Transplant, vol.23, pp.283-290, 1999.

S. Bozza, F. Kasermann, S. V. Kaveri, L. Romani, and J. Bayry, Intravenous immunoglobulin protects from experimental allergic bronchopulmonary aspergillosis via a sialylation-dependent mechanism, Eur. J. Immunol, vol.49, pp.195-198, 2019.

M. S. Maddur, S. V. Kaveri, and J. Bayry, Circulating normal igg as stimulator of regulatory t cells: Lessons from intravenous immunoglobulin, Trends Immunol, vol.38, pp.789-792, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01630293

S. Othy, S. Topcu, C. Saha, P. Kothapalli, S. Lacroix-desmazes et al., Sialylation may be dispensable for reciprocal modulation of helper t cells by intravenous immunoglobulin, Eur. J. Immunol, vol.44, pp.2059-2063, 2014.

, Int. J. Mol. Sci, vol.20, p.1473, 2019.

A. N. Neely and I. A. Holder, Effects of immunoglobulin g and low-dose amphotericin b on candida albicans infections in burned mice, Antimicrob Agents Chemother, vol.36, pp.643-646, 1992.

A. Darfeuille-michaud, C. Neut, N. Barnich, E. Lederman, P. Di-martino et al., Presence of adherent escherichia coli strains in ileal mucosa of patients with crohn's disease, Gastroenterology, vol.115, pp.1405-1413, 1998.

S. C. Kim, S. L. Tonkonogy, T. Karrasch, C. Jobin, and R. B. Sartor, Dual-association of gnotobiotic il-10-/-mice with 2 nonpathogenic commensal bacteria induces aggressive pancolitis, Inflamm. Bowel Dis, vol.13, pp.1457-1466, 2007.

G. Hoarau, P. K. Mukherjee, C. Gower-rousseau, C. Hager, J. Chandra et al., Bacteriome and mycobiome interactions underscore microbial dysbiosis in familial crohn's disease, MBio, vol.7, pp.1250-1266, 2016.

A. Croasdell, P. F. Duffney, N. Kim, S. H. Lacy, P. J. Sime et al., Ppargamma and the innate immune system mediate the resolution of inflammation, Ppar Res, vol.549691, 2015.

V. Ruiz-de-souza, M. P. Carreno, S. V. Kaveri, A. Ledur, H. Sadeghi et al., Selective induction of interleukin-1 receptor antagonist and interleukin-8 in human monocytes by normal polyspecific igg (intravenous immunoglobulin), Eur. J. Immunol, vol.25, pp.1267-1273, 1995.

L. K. Kozicky, Z. Y. Zhao, S. C. Menzies, M. Fidanza, G. S. Reid et al., Intravenous immunoglobulin skews macrophages to an anti-inflammatory, il-10-producing activation state, J. Leukoc Biol, vol.98, pp.983-994, 2015.

C. Galeotti, P. Hegde, M. Das, E. Stephen-victor, F. Canale et al., Heme oxygenase-1 is dispensable for the anti-inflammatory activity of intravenous immunoglobulin, Sci. Rep, vol.6, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01274079

S. Casulli, S. Topcu, L. Fattoum, S. Von-gunten, H. U. Simon et al., A differential concentration-dependent effect of ivig on neutrophil functions: Relevance for anti-microbial and anti-inflammatory mechanisms, PLoS ONE, 2011.

C. Schneider, S. Wicki, S. Graeter, T. M. Timcheva, C. W. Keller et al., Ivig regulates the survival of human but not mouse neutrophils

A. C. Vos, M. E. Wildenberg, M. Duijvestein, A. P. Verhaar, G. R. Van-den-brink et al., Anti-tumor necrosis factor-alpha antibodies induce regulatory macrophages in an fc region-dependent manner, Gastroenterology, vol.140, pp.221-230, 2011.

Y. Peng, H. Liu, F. Liu, H. Wang, Y. Liu et al., Inhibitory effect of ppar-gamma activator on il-6 and mpges protein expression in pbmc induced by homocysteine, Hemodial Int, vol.9, 2005.

M. Fukata, A. Chen, A. S. Vamadevan, J. Cohen, K. Breglio et al., Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors, Gastroenterology, vol.133, pp.1869-1881, 2007.

R. Charlet, Y. Pruvost, G. Tumba, F. Istel, D. Poulain et al., Remodeling of the candida glabrata cell wall in the gastrointestinal tract affects the gut microbiota and the immune response

C. Bortolus, M. Billamboz, R. Charlet, K. Lecointe, B. Sendid et al., A small aromatic compound has antifungal properties and potential anti-inflammatory effects against intestinal inflammation, Int. J. Mol. Sci, vol.20, p.321, 2019.

S. Jawhara, K. Habib, F. Maggiotto, G. Pignede, P. Vandekerckove et al., Modulation of intestinal inflammation by yeasts and cell wall extracts: Strain dependence and unexpected anti-inflammatory role of glucan fractions, PLoS ONE, vol.7, 2012.
URL : https://hal.archives-ouvertes.fr/pasteur-01721842